News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Estela Rodriguez: Honored to join thought leaders seeking solutions in biomarker testing
Estela Rodriguez/doctors.umiamihealth.org
Apr 19, 2025, 18:46

Estela Rodriguez: Honored to join thought leaders seeking solutions in biomarker testing

Estela Rodriguez, Associate Director, Community Outreach of Thoracic Oncology at Sylvester Comprehensive Cancer Center, shared a post on X:

“Thank you, Balazs Halmos, for the support and photobomb at the ACS National Lung Cancer Roundtable 2025 Biomarker Workshop with Kelly Mercier.

Honored to be in this room with many thought leaders trying to find solutions to Biomarker testing and timely/equitable treatment for lung cancer patients.”

Estela Rodriguez: Honored to join thought leaders seeking solutions in biomarker testing

More posts featuring Estela Rodriguez.

ACS National Lung Cancer Roundtable Balazs Halmos Biomarker Workshop cancer Estela Rodriguez Kelly Mercier NLCRT OncoDaily Oncology
Special Coverage
Oncolibrary
Jun 1, 2025, 18:59
SERENA-6 Trial at ASCO 2025: Camizestrant Plus CDK4/6i Improves Outcomes in HR+/HER2– Advanced Breast Cancer with ctDNA-Detected ESR1 Mutations
Blog
Jun 1, 2025, 18:09
Michael Jefford: Grateful for ASCO25’s Valuable Survivorship Session
Stories
Jun 1, 2025, 17:19
Shrenik Shah’s Story from Cancer Survivor to Global Advocate: From Silence to Stages
Insight
Jun 1, 2025, 17:02
Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney
Blog
Jun 1, 2025, 16:55
Oriol Mirallas: Early Data on SYNC-T Therapy for mCRPC Presented at ASCO 2025
Blog
Jun 1, 2025, 16:52
Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025
Insight
Jun 1, 2025, 16:46
Shanda Blackmon: First trial of CAR-T cell cancer treatment for solid tumor response
Oncolibrary
Jun 1, 2025, 16:39
MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment
Opinion
Jun 1, 2025, 16:37
Massimo Di Maio: Overall Survival Analysis Should NOT be Adjusted for Subsequent Treatments
Blog
Jun 1, 2025, 16:37
Paolo Tarantino Shares DB06 Biomarker Analysis Insights from ASCO 2025
Insight
Jun 1, 2025, 16:36
Rebecca Shatsky: It’s high time for an oral taxane in breast cancer
Blog
Jun 1, 2025, 16:26
Runcie C.W. Chidebe: Project PINK BLUE is Exhibiting at the ASCO25 Annual Meeting